# Assurant, Inc.: overview

AIZ · NYSE · CIK 1267238 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aiz.md) · [Financials](/companies/aiz/financials.md) · [Filings](/companies/aiz/filings.md) · [Insiders](/companies/aiz/insiders.md)

Latest reported revenue: [$3.45bn](/filings/0001267238-26-000041.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:Revenues, accession 0001267238-26-000041).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,968](/filings/0001267238-25-000051.md) | [3,105 d](/filings/0001267238-26-000010.md) | [3,074](/filings/0001267238-26-000027.md) | [3,158](/filings/0001267238-26-000041.md) | [3,232](/filings/0001267238-25-000051.md) | [3,350 d](/filings/0001267238-26-000010.md) | [3,420](/filings/0001267238-26-000027.md) | [3,454](/filings/0001267238-26-000041.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [4.5%](/filings/0001267238-25-000051.md) | [6.5% d](/filings/0001267238-26-000010.md) | [4.8%](/filings/0001267238-26-000027.md) | [7.4%](/filings/0001267238-26-000041.md) | [8.2%](/filings/0001267238-25-000051.md) | [6.7% d](/filings/0001267238-26-000010.md) | [8.0%](/filings/0001267238-26-000027.md) | [8.6%](/filings/0001267238-26-000041.md) |
| Diluted EPS | $ per share | [2.55](/filings/0001267238-25-000051.md) | not reported | [2.83](/filings/0001267238-26-000027.md) | [4.56](/filings/0001267238-26-000041.md) | [5.17](/filings/0001267238-25-000051.md) | not reported | [5.41](/filings/0001267238-26-000027.md) | [5.95](/filings/0001267238-26-000041.md) |
| Free cash flow | $m | [389 d](/filings/0001267238-25-000051.md) | [34.8 d](/filings/0001267238-26-000010.md) | [339](/filings/0001267238-26-000027.md) | [206 d](/filings/0001267238-26-000041.md) | [442 d](/filings/0001267238-25-000051.md) | [612 d](/filings/0001267238-26-000010.md) | [193](/filings/0001267238-26-000027.md) | [409 d](/filings/0001267238-26-000041.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [10.2](/filings/0001267238-24-000008.md) | [10.2](/filings/0001267238-25-000008.md) | [11.1](/filings/0001267238-26-000010.md) | [11.9](/filings/0001267238-26-000010.md) | [12.8](/filings/0001267238-26-000010.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [13.4%](/filings/0001267238-24-000008.md) | [2.7%](/filings/0001267238-25-000008.md) | [5.8%](/filings/0001267238-26-000010.md) | [6.4%](/filings/0001267238-26-000010.md) | [6.8%](/filings/0001267238-26-000010.md) |
| Diluted EPS | $ per share | [22.66](/filings/0001267238-24-000008.md) | [5.05](/filings/0001267238-25-000008.md) | [11.95](/filings/0001267238-26-000010.md) | [14.46](/filings/0001267238-26-000010.md) | [16.93](/filings/0001267238-26-000010.md) |
| Free cash flow | $bn | [0.6](/filings/0001267238-24-000008.md) | [0.4](/filings/0001267238-25-000008.md) | [0.9](/filings/0001267238-26-000010.md) | [1.1](/filings/0001267238-26-000010.md) | [1.6](/filings/0001267238-26-000010.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/aiz/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.35bn | 5,009,537 |  | Added +1,063,661 |
| [Bank of New York Mellon Corp](/funds/1390777.md) | 2026-06-30 | $1.27bn | 4,727,930 |  | Reduced −89,021 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $869.2m | 3,236,936 |  | Reduced −6,568 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $761.6m | 2,836,307 |  | Reduced −171,830 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $682.6m | 2,541,897 |  | Added +10,481 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $379.9m | 1,417,209 |  | Added +10,423 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $329.4m | 1,226,729 |  | Added +282 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $322.0m | 1,199,305 |  | Added +73,899 |
| [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $269.6m | 1,004,116 |  | Added +642,906 |
| [MASSACHUSETTS FINANCIAL SERVICES CO /MA/](/funds/912938.md) | 2026-06-30 | $247.2m | 920,398 |  | Reduced −2,023 |

## Recent filings

[All 1,575 filings](/companies/aiz/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 20:18 ET | [10-Q](/filings/0001267238-26-000041.md) | Quarterly report, period 2026-06-30 | 0001267238-26-000041 |
| 2026-08-04 | 20:30 ET | [8-K](/filings/0001267238-26-000039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001267238-26-000039 |
| 2026-05-22 | 20:23 ET | [8-K](/filings/0001267238-26-000033.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001267238-26-000033 |
| 2026-05-07 | 20:19 ET | [10-Q](/filings/0001267238-26-000027.md) | Quarterly report, period 2026-03-31 | 0001267238-26-000027 |
| 2026-05-05 | 18:01 ET | [8-K](/filings/0001267238-26-000024.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001267238-26-000024 |
| 2026-04-06 | 20:17 ET | [DEF 14A](/filings/0001267238-26-000018.md) | Proxy statement, period 2026-05-21 | 0001267238-26-000018 |
| 2026-02-19 | 21:19 ET | [10-K](/filings/0001267238-26-000010.md) | Annual report, period 2025-12-31 | 0001267238-26-000010 |
| 2026-02-10 | 21:21 ET | [8-K](/filings/0001267238-26-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001267238-26-000006 |
| 2026-01-28 | 22:21 ET | [8-K](/filings/0001267238-26-000003.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001267238-26-000003 |
| 2025-11-06 | 21:21 ET | [10-Q](/filings/0001267238-25-000051.md) | Quarterly report, period 2025-09-30 | 0001267238-25-000051 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001267238-26-000010.md), filed Feb 19, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/d56283c5-0e29-4f4f-82eb-842c45262a2d)

## About the filer

- CIK: 1267238
- Tickers: AIZ, AIZN
- Exchange: NYSE
- SIC code: 6399 Insurance Carriers, NEC
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.